{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:12:03Z","timestamp":1784621523400,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"NSTC","doi-asserted-by":"publisher","award":["112-2320-B-038 -030 -"],"award-info":[{"award-number":["112-2320-B-038 -030 -"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ejmech.2024.116507","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T07:06:23Z","timestamp":1715929583000},"page":"116507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Leveraging a rationally designed veliparib-based anilide eliciting anti-leukemic effects for the design of pH-responsive polymer nanoformulation"],"prefix":"10.1016","volume":"273","author":[{"given":"Amandeep","family":"Thakur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsuan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Vijayakameswara","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajmer Singh","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhita","family":"Prabakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Guru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Ping","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hsu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Nepali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116507_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2020.102951","article-title":"DNA repair pathways as guardians of the genome: therapeutic potential and possible prognostic role in hematologic neoplasms","volume":"96","author":"Rahimian","year":"2020","journal-title":"DNA Repair"},{"issue":"5","key":"10.1016\/j.ejmech.2024.116507_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/em.22087","article-title":"Mechanisms of DNA damage, repair, and mutagenesis","volume":"58","author":"Chatterjee","year":"2017","journal-title":"Environ. Mol. Mutagen."},{"issue":"18","key":"10.1016\/j.ejmech.2024.116507_bib3","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.3390\/ijms21186684","article-title":"Inhibition of DNA repair in cancer therapy: toward a multi-target approach","volume":"21","author":"Lodovichi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116507_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/mco2.103","article-title":"Targeting DNA repair pathway in cancer: mechanisms and clinical application","volume":"2","author":"Wang","year":"2021","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116507_bib5","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1038\/ncomms3240","article-title":"A systematic analysis of the PARP protein family identifies new functions critical for cell physiology","volume":"4","author":"Vyas","year":"2013","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116507_bib6","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/ijc.33918","article-title":"PARP mediated DNA damage response, genomic stability and immune responses","volume":"150","author":"Zong","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.ejmech.2024.116507_bib7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/1947601910383418","article-title":"Upregulation of poly (ADP-ribose) polymerase-1 (PARP1) in triple-negative breast cancer and other primary human tumor types","volume":"1","author":"Ossovskaya","year":"2010","journal-title":"Genes & cancer"},{"key":"10.1016\/j.ejmech.2024.116507_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-06903-4","article-title":"Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells","volume":"20","author":"Gil-Kulik","year":"2020","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ejmech.2024.116507_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/gtmb.2018.0085","article-title":"PARP-1 overexpression as an independent prognostic factor in adult non-M3 acute myeloid leukemia","volume":"22","author":"Pashaiefar","year":"2018","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116507_bib10","first-page":"328","article-title":"PARP-1 and PARP-2: new players in tumour development","volume":"1","author":"Yelamos","year":"2011","journal-title":"Am. J. Cancer Res."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116507_bib11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1080\/17460441.2023.2241818","article-title":"Prudent tactics to sail the boat of PARP inhibitors as therapeutics for diverse malignancies","volume":"18","author":"Rana","year":"2023","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116507_bib12","article-title":"A bi-functional PARP-HDAC inhibitor with activity in Ewing sarcoma","volume":"CCR-22\u20133897","author":"Ramos","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116507_bib13a","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2024.116507_bib13b","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.578011","article-title":"Synergistic enhancement of cancer therapy using HDAC inhibitors: opportunity for clinical trials","volume":"11","author":"Hontecillas-Prieto","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejmech.2024.116507_bib14","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.2174\/1568026619666181210152115","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"18","author":"Sun","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2024.116507_bib15","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1021\/acs.jmedchem.0c00491","article-title":"Dual-target inhibitors based on HDACs: novel antitumor agents for cancer therapy","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116507_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.molonc.2015.12.014","article-title":"Enhanced efficacy of combined HDAC and PARP targeting in glioblastoma","volume":"10","author":"Rasmussen","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejmech.2024.116507_bib17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.biopha.2018.01.045","article-title":"Co-targeting poly (ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: higher synergism in BRCA mutated cells","volume":"99","author":"Marijon","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116507_bib18","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1158\/1541-7786.MCR-14-0173","article-title":"Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP","volume":"12","author":"Chao","year":"2014","journal-title":"Mol. Cancer"},{"issue":"19","key":"10.1016\/j.ejmech.2024.116507_bib19","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1182\/bloodadvances.2020002049","article-title":"The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1","volume":"4","author":"Kruglov","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116507_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0810-7","article-title":"PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1\/BRCA1 DNA damage repair complex in prostate cancer cells","volume":"37","author":"Yin","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116507_bib21","first-page":"1","article-title":"Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells","author":"Vollmer","year":"2023","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.ejmech.2024.116507_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114602","article-title":"Accommodation of ring C expanded deoxyvasicinone in the HDAC inhibitory pharmacophore culminates into a tractable anti-lung cancer agent and pH-responsive nanocarrier","volume":"240","author":"Sharma","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116507_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111294","article-title":"Polynorbornene-derived block copolymer micelles via ring\u2010opening metathesis polymerization with capacity of hydrogen sulfide generation","volume":"173","author":"Le","year":"2022","journal-title":"Eur. Polym. J."},{"issue":"20","key":"10.1016\/j.ejmech.2024.116507_bib24","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1039\/C8NR00888D","article-title":"ROS-responsive mesoporous silica nanoparticles for MR imaging-guided photodynamically maneuvered chemotherapy","volume":"10","author":"Rao","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejmech.2024.116507_bib25a","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fbioe.2018.00110","article-title":"Recent progress and advances in stimuli-responsive polymers for cancer therapy","volume":"6","author":"Rao","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"260","key":"10.1016\/j.ejmech.2024.116507_bib25b","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2017.05.028","article-title":"PEG-PCL-based nanomedicines: a biodegradable drug delivery system and its application","volume":"28","author":"Grossen","year":"2017","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116507_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1021\/jm801171j","article-title":"Discovery of the poly (ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1 H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer","volume":"52","author":"Penning","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116507_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106893","article-title":"Small molecule tractable PARP inhibitors: scaffold construction approaches, mechanistic insights and structure activity relationship","author":"Thakur","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2024.116507_bib28","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.bmcl.2005.07.081","article-title":"Exploring the connection unit in the HDAC inhibitor pharmacophore model: novel uracil-based hydroxamates","volume":"15","author":"Mai","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116507_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1021\/jm301254q","article-title":"Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells","volume":"56","author":"Marek","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116507_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130590","article-title":"Appraisal of pyrrole as connecting unit in hydroxamic acid based histone deacetylase inhibitors: synthesis, anticancer evaluation and molecular docking studies","volume":"1240","author":"Singh","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116507_bib31","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nchembio.1908","article-title":"Chemical proteomics reveals a \u03b3H2AX-53BP1 interaction in the DNA damage response","volume":"11","author":"Kleiner","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116507_bib32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1101\/gad.183509.111","article-title":"On PAR with PARP: cellular stress signaling through poly (ADP-ribose) and PARP-1","volume":"26","author":"Luo","year":"2012","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116507_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108151","article-title":"Endogenous cyclin D1 promotes the rate of onset and magnitude of mitogenic signaling via Akt1 Ser473 phosphorylation","volume":"32","author":"Chen","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2024.116507_bib34","article-title":"Akt: a double-edged sword in cell proliferation and genome stability","volume":"2012","author":"Xu","year":"2012","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116507_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4161\/auto.5338","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes","volume":"4","author":"Klionsky","year":"2008","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116507_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2276665","article-title":"Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer","volume":"38","author":"Sharma","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116507_bib37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116507_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/10717544.2012.657721","article-title":"Investigation on design of stable etoposide-loaded PEG-PCL micelles: effect of molecular weight of PEG-PCL diblock copolymer on the in vitro and in vivo performance of micelles","volume":"19","author":"Ukawala","year":"2012","journal-title":"Drug Deliv."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116507_bib39","doi-asserted-by":"crossref","first-page":"8325","DOI":"10.1021\/acsabm.1c00847","article-title":"Hyaluronic acid derived hypoxia-sensitive nanocarrier for tumor targeted drug delivery","volume":"4","author":"Le","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ejmech.2024.116507_bib40","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2147\/IJN.S39532","article-title":"Preparation, characterization and application of star-shaped PCL\/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer","author":"Gao","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116507_bib41","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1080\/10601325.2023.2265961","article-title":"A hyaluronic-based prodrug with aggregation-induced emission for drug delivery and cellular imaging","volume":"60","author":"Pham","year":"2023","journal-title":"J. Macromol. Sci., Part A"},{"issue":"17","key":"10.1016\/j.ejmech.2024.116507_bib42","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/asia.202100355","article-title":"Efficient design to monitor the site\u2010specific sustained release of a non\u2010emissive anticancer drug","volume":"16","author":"Venu","year":"2021","journal-title":"Chem. Asian J."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116507_bib43","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nsb1203-980","article-title":"Announcing the worldwide protein data bank","volume":"10","author":"Berman","year":"2003","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"16","key":"10.1016\/j.ejmech.2024.116507_bib44","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116507_bib45","doi-asserted-by":"crossref","first-page":"W622","DOI":"10.1093\/nar\/gkq325","article-title":"Frog2: efficient 3D conformation ensemble generator for small compounds","volume":"38","author":"Miteva","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116507_bib46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116507_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pat.975","article-title":"Degradation behaviors of monomethoxy poly (ethylene glycol)\u2010b\u2010poly (\u03b5\u2010caprolactone) nanoparticles in aqueous solution","volume":"19","author":"Shen","year":"2008","journal-title":"Polym. Adv. Technol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116507_bib48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijpharm.2017.09.054","article-title":"Technical aspects of preparing PEG-PLGA nanoparticles as carrier for chemotherapeutic agents by nanoprecipitation method","volume":"533","author":"Almoustafa","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116507_bib49","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1021\/mp300350e","article-title":"Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: a novel application in pediatric nanomedicine","volume":"10","author":"Krishnan","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2024.116507_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.112646","article-title":"ROS-responsive camptothecin-linked thioketal drug delivery system based on ring-closing polymerization","volume":"202","author":"Mathew","year":"2024","journal-title":"Eur. Polym. J."},{"issue":"20","key":"10.1016\/j.ejmech.2024.116507_bib51","article-title":"Plasma-enabled graphene quantum dot hydrogels as smart anticancer drug nanocarriers","volume":"19","author":"Kurniawan","year":"2023","journal-title":"Small"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424003878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424003878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:11:23Z","timestamp":1778735483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424003878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":53,"alternative-id":["S0223523424003878"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116507","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leveraging a rationally designed veliparib-based anilide eliciting anti-leukemic effects for the design of pH-responsive polymer nanoformulation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116507"}}